Journal of Endocrinological Investigation

, Volume 18, Issue 8, pp 630–637 | Cite as

Binding of GC (VDBP) to membranes of human B lymphocytes following stripping of extant protein

  • Mario Petrini
  • A. Allegrini
  • F. Ambrogi
  • P. Valentini
  • A. Sabbatini
  • P. Arnaud
  • R. M. Galbraith


The presence of Gc (vitamin D binding protein) has been consistently demonstrated on the membrane of B lymphocytes. This protein appears to be spatially associated with surface immunoglobulins. The origin of this surface protein has not yet been determined and the purpose of the present paper was to investigate if Gc may bind to human lymphocytes after immunoglobulin (Ig) capping. For this purpose the presence of Gc on B lymphocytes was examined by three different approaches. First, when cells were examined by immunofluorescence and quantified by flow cytometry, membrane Ig capping was followed by a dramatic decrease in positivity for Gc when compared to native cells. In addition, incubation of capped cells with purified Gc was followed by a significant increase in fluorescence, indicating that this protein had been able to bind again. Second, analysis of solubilized lymphocytes by Western blotting showed that native lymphocytes and capped cells incubated with purified Gc contained a large quantity of a 56kDa protein which was immunoreactive with anti Gc antibodies. This protein band was much weaker on blots from capped cells not treated with Gc. Third, radiobinding assays indicated that, following capping, cells were able to bind Gc in saturable fashion. These results suggest that membrane Gc could play a role in the entry of vitamin D metabolites into lymphocytes.


GC VDBP B lymphocytes lg capping surface immunoglobulin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Daiger S.P., Shanfield M.S., Cavalli-Sforza L.L. Group-specific component (Gc) proteins bind vit. D and 25 hydroxyvitamin D. Proc. Natl. Acad. Sci. USA 72:2076, 1975.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Putnam F.W. The plasma proteins: structure, function and genetic control, ed. 2. Academic Press, New York, 1984, vol. 4, p. 93.Google Scholar
  3. 3.
    Van Baelen I.I., Bouillon R., De Moor P., Tan B.K. Isolation and characterization of the 25-hydroxyvitamin D binding protein from the chick serum. J. Biol. Chem. 255:10925, 1980.PubMedGoogle Scholar
  4. 4.
    Haddan J.G. Humman serum binding protein for vit. D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal muscle. Arch. Biochem. Byophys. 213:538, 1982.CrossRefGoogle Scholar
  5. 5.
    Williams M.H., Van Alstyne G., Galbraith R.M. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D binding protein). Bichem. Byophys. Res. Commun. 153:1019, 1988.CrossRefGoogle Scholar
  6. 6.
    Cooke N.F., David F.V. Serum vitamin D binding protein is a third member of the albumin and alpha fetoprotein gene family. J. Clin. Invest. 76:2420, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Yang F., Brune J.L., Naylor S.L., Cupples R.L., Naberhaus K.H., Bowman B.H. Human group specific component (Gc) is a member of the albumin family. Proc. Natl. Acad. Sci. USA 82:7994, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Cooke N.F., Haddad J.G. Vitamin D binding protein (Gc-Globulin). Endocr. Rev. 10:294, 1989.PubMedCrossRefGoogle Scholar
  9. 9.
    Constans J., Orsman F., Vian M. Binding of the apo and holo forms of the vitamin D binding protein to human lymphocyte cytoplasm and membranes by indirect immunofluorescence. Immunol. Lett. 3:159, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Petrini M., Emerson D.L., Galbraith R.M. Linkage between surface immunoglobulins and cytoskeletton of B lymphocytes may involve Gc protein. Nature 306:73. 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Petrini M., Galbraith R.M., Werner P.A.M., Emerson D.L., Arnaud P. Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes. Clin. Immunol. Immunopathol. 31:282, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Petrini M., Carulli G., Ambrogi F., Galbraith R.M. Phenotypic markers in chronic lymphocytic leukemia. N. Engl. J. Med. 314:1514, 1986.PubMedGoogle Scholar
  13. 13.
    Petrini M., Galbraith R.M., Emerson D.L., Nel A.E., Arnaud P. Structural studies of lymphocyte Fc receptors. Association of Gc with IgG binding Fc gamma. J. Biol. Chem. 260:1804, 1985.PubMedGoogle Scholar
  14. 14.
    Machii T., Kimura I.I., Ueda E., Chujo T., Morita T., Katagiri S., Tagawa S., Kitani T. Distribution of Gc protein (Vitamin D binding protein) on the surface of normal human lymphocytes and leukemia lymphocytes. Acta Haematol. 75:26, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    McLeod J.F., Kowaiski M.A., Haddad J.G. Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes. Endocrinology 119:77, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Gouth M., Murgia A., Siegel D., Smith R.M., Prytowsky M.B., Cooke N.E., Haddad J.G. Cell surface vitamin D binding protein (Gc-globulin) is acquired from plasma. Endocrinology 127:2313, 1990.CrossRefGoogle Scholar
  17. 17.
    Ambrogi F., Petrini M., Carulli G., Caracciolo F., Testi R., Cappelli N., Ronca-Testoni S., Polidori R., Grassi B. Adenosine deaminase in human cord blood lymphocyte subpopulations. Cell. Immunol. 73:404, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Nadler L.M., Anderson K.C., Marti G., Bates M., Park E., Daley J.F., Schlossman S.J. B4 a human B lymphocyte associated antigen expressed on normal, mitogen activated and malignant B lymphocytes. J. Immunol. 131:244, 1983.PubMedGoogle Scholar
  19. 19.
    Esteban C., Geuskens M., Ena J.M., Mishal Z., Macho A., Torres J., Uriel J. Receptor-mediated uptake and processing of vitamin D-binding protein in human B-lymphoid cells. J. Biol. Chem. 267;10177, 1992.Google Scholar
  20. 20.
    Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1.25 dihydroxyvitamin D3 in human leukocytes. Science 221:1181, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Petrini M., Valentini P., Allegrini A., Sabbatini A., Testi R., Ambrogi F., Arnaud P., Galbraith R.M. Is binding of vitamin D binding protein related to cell differentiation? Leukemia Res. 17:561, 1993.CrossRefGoogle Scholar
  22. 22.
    Nestler J.E., McLeod J.F., Kowalsky M.A., Strauss J.F., Haddan J.G. Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. Endocrynology 120:1996, 1987.CrossRefGoogle Scholar
  23. 23.
    Vanham G., Van Baelen H., Tan B.K., Bouillon R.J. The effect of the vitamin D analogs and the vitamin D binding protein on lymphocyte proliferation. Steroid Biochem. 29:381, 1988.CrossRefGoogle Scholar
  24. 24.
    Chen W.C., Vaynegula B., Gupta S. 1,25 dihydroxyvitamin D3 mediated inhibition of human B cell differentiation. Clin. Exp. Immunol. 69:639, 1987.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Komoriya K., Nagata L., Tsuchimoto M., Kunisawa K., Takeshita T., Naruchi T. 1,25 dihydroxyvitamin D3 suppresses in vitro antibody response to T cell dependent antigen. Biochem. Biophys. Res. Commun. 127:753, 1985.PubMedCrossRefGoogle Scholar
  26. 26.
    Lemire J.M., Adams J.S., Sakai R., Jordan S.C. 1 alpha, 25 dihydroxyvitamin D3 suppresses proliferation and immunoglobulins production by normal human peripheral blood mononuclear cells. J.Clin. Invest. 74:657, 1984.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1995

Authors and Affiliations

  • Mario Petrini
    • 1
  • A. Allegrini
    • 1
  • F. Ambrogi
    • 1
  • P. Valentini
    • 1
  • A. Sabbatini
    • 1
  • P. Arnaud
    • 2
  • R. M. Galbraith
    • 2
  1. 1.Unità di Ematologia, Clinica Medica 1University of PisaPisaItaly
  2. 2.Departments of Microbiology and Immunology, and MedicineMedical University of South CarolinaCharlestonUSA

Personalised recommendations